Experienced in Polymyalgia Rheumatica

Takeshi Kondo

Sapporo, JP 
Experienced in Polymyalgia Rheumatica
Sapporo, JP 
OverviewLocationsClinical Research

Overview

Takeshi Kondo practices in Sapporo, Japan. Mr. Kondo is rated as an Experienced expert by MediFind in the treatment of Polymyalgia Rheumatica. His top areas of expertise are Leukemia, Chronic Myelogenous Leukemia (CML), Gastrointestinal Perforation, Bone Marrow Transplant, and Thrombectomy.

His clinical research consists of co-authoring 491 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Polymyalgia Rheumatica.

Gender
Male

Locations

Sapporo, 0640804, Japan
Other Locations
Kashiwa, Japan
Gifu-shi, Japan
Nagoya, Japan
Komaba, 1538505, Japan
Kobe, Japan
Osaka, 5778502, Japan
3058565, Japan
Tokushima, Japan
Noda, 2788510, Japan
Wakayama, Japan
Tokyo, 1130033, Japan
Komatsushimacho, Japan
Hitachi, Japan
Hamamatsu, Japan
Yamanashi, Japan
Toyoake, 4701192, Japan
Chiba, Japan
Sugitani, 9300194, Japan
Nagakute, Japan
Hiroshima, Japan
Kyoto, Japan
Suita, 5650871, Japan
Kawahara, 6068507, Japan
Nishinomiya-hama, Japan
Toyama, Japan
Yokosuka, Japan
Takasaki, Japan
Miyoshi, Japan
Ogaki, Japan
Kanagawa, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3

491 Total Publications

Validation of gradient-boosted models for non-invasive diagnosis of myelodysplastic neoplasms: a single-center analysis
Validation of gradient-boosted models for non-invasive diagnosis of myelodysplastic neoplasms: a single-center analysis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kondo's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 149 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile